Atlas Trials

A Study of Sinotecean on Tolerance and Pharmacokinetics

Clinical trial NCT02469883 · UNKNOWN

Trial details

NCT number
NCT02469883
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Cancer
Start date
2015-03-01
Primary completion
2016-08-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.